Proteomics of p53 in Diagnostics and Therapy of Acute Myeloid Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|7|3|199-207

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.3, 2006-06, pp. : 199-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Therapy for Acute Myeloid Leukemia

By Kohrt Holbrook E.   Coutre Steven E.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 1003-1016

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 86-105

Bentham Science Publishers

Access to resources Recommend Favorite

Development of personalized molecular therapy for acute myeloid leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 20-29

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Cytotoxic Activity of Recombinant TRAIL Plus the Non-Genotoxic Activator of the p53 Pathway Nutlin-3 in Acute Myeloid Leukemia Cells

By  

Current Drug Metabolism, Vol. 8, Iss. 4, 2007-05 ,pp. : 395-403

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite